Scottsdale, Nov 24, 2020 (Issuewire.com) - Resonea is proud to announce the commercial launch of their FDA-cleared digital home sleep test DROWZLE® PRO after positive early experience results. DROWZLE PRO is the only home sleep test using smartphone technology to identify obstructive sleep apnea (OSA). With the acceleration of telemedicine due to the COVID-19 pandemic, DROWZLE PRO's innovative platform provides a clear advantage over traditional home sleep testing machines that are reused between patients and risk contamination.
DROWZLE PRO was launched in several sleep medicine practices in California, Tennessee, and Georgia in early 2020 and is now being offered nationwide after strong reviews from providers and patients alike. Dr. Avi Bhar, an innovative sleep physician in Macon, Georgia and an early adopter of DROWZLE PRO, says, "DROWZLE PRO has provided more access for patients who suffer from OSA symptoms but have never been diagnosed. It is a very easy platform to use for both my patients and me, and I trust the results."
OSA affects over 20 million Americans, with 80% being undiagnosed. OSA worsens other chronic diseases such as diabetes, hypertension, depression, and stroke, making these more challenging to treat. Early identification and treatment of OSA can help improve these other chronic medical conditions and empower patients to manage their condition and feel better. DROWZLE PRO can be used to identify OSA in large populations as it is deployed digitally and is cost-effective.
"We created DROWZLE PRO to reduce barriers and increase access to more patients. The technology greatly reduces the time it takes for a patient to receive a diagnosis, consultation, and treatment for OSA from weeks to just a few days, all done virtually from the comfort of one's home," says Resonea's Chief Medical Officer Karen R. Underwood, MD.
Located in Scottsdale, AZ, and established in 2016. Resonea, Inc. is a Sleep Health technology company whose mission is to advance sleep health science to improve performance, safety, and quality-of-life. Resonea's comprehensive Sleep Health Program includes DROWZLE® PRO, the first-ever smartphone-based home sleep test cleared by the FDA, which transforms the way obstructive sleep apnea is detected using only a mobile phone. Resonea's technology allows for widespread access to sleep health services while keeping patients safe in their own homes.
Dr. Avinesh Bhar is a board-certified pulmonary and sleep, medicine physician. Dr. Bhar provides sleep and pulmonary telemedicine services to patients in Georgia, South Carolina, Virginia, Texas, Arkansas, Minnesota, and Florida through his virtual practice at sliiip.com. Dr. Bhar also provides interpreter services for DROWZLE PRO.
11445 East Via LindaSuite 2, Box 224
Source :Resonea, Inc.
This article was originally published by IssueWire. Read the original article here.